Dietmar Falke

Effectiveness and Safety of Tapentadol Prolonged Release (<scp>PR</scp>) Versus a Combination of Tapentadol <scp>PR</scp> and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

Ralf Baron, E. Martín‐Mola, Matthias Müller et al. · Pain Practice · 2014 · 71 citations · Full text

Nursing, Pharmacotherapy, Pain Management +16

Effectiveness of Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study

Ralf Baron, Rudolf Likar, E. Martín‐Mola et al. · Pain Practice · 2015 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial

Ralf Baron, Jan‐Peter Jansen, Andreas Binder et al. · Pain Practice · 2015 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain

Ilona Steigerwald, Michael Schenk, Uwe Lahne et al. · Clinical Drug Investigation · 2013 · 47 citations · Full text

Nursing, Pharmacotherapy, Orthopedics +13

Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study

Rafael Gálvez, Michael Schäfer, Guy Hans et al. · Advances in Therapy · 2013 · 45 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17